{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:28:50Z","timestamp":1769603330824,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.seminoncol.2025.152388","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T12:42:14Z","timestamp":1753188134000},"page":"152388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Germline mutations in B-cell non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) and patient outcomes"],"prefix":"10.1016","volume":"52","author":[{"given":"Xing","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aibin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.seminoncol.2025.152388_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41375-024-02135-8","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis","volume":"38","author":"Knauft","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.seminoncol.2025.152388_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.788056","article-title":"Clinical features and prognostic risk prediction of non-hodgkin lymphoma-associated hemophagocytic syndrome","volume":"11","author":"Yao","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152388_bib0003","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2352-3026(21)00366-5","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis","volume":"9","author":"Setiadi","year":"2022","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152388_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10428194.2018.1482543","article-title":"Hemophagocytic lymphohistiocytosis in adults","volume":"60","author":"Bhatt","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"17","key":"10.1016\/j.seminoncol.2025.152388_bib0005","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2016-03-700609","article-title":"HLH susceptibility: genetic lesions add up","volume":"127","author":"Meeths","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.seminoncol.2025.152388_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1210041","article-title":"Approaching hemophagocytic lymphohistiocytosis","volume":"14","author":"Chinnici","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152388_bib0007","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11596-021-2375-5","article-title":"Inherited genetic susceptibility to nonimmunosuppressed Epstein-Barr Virus-associated T\/NK-cell lymphoproliferative diseases in Chinese patients","volume":"41","author":"Guan","year":"2021","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.seminoncol.2025.152388_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1365975","article-title":"Germline defects of familial hemophagocytic lymphohistiocytosis-related genes presenting as adult-onset peripheral T-cell lymphoma","volume":"15","author":"Wei","year":"2024","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152388_bib0009","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s10875-017-0443-1","article-title":"Effective immunological guidance of genetic analyses including exome sequencing in patients evaluated for hemophagocytic lymphohistiocytosis","volume":"37","author":"Ammann","year":"2017","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.seminoncol.2025.152388_bib0010","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1038\/bcj.2017.22","article-title":"Germline mutations predisposing to diffuse large B-cell lymphoma","volume":"7","author":"Leeksma","year":"2017","journal-title":"Blood Cancer J"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152388_bib0011","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152388_bib0012","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40164-021-00229-y","article-title":"Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis","volume":"10","author":"Ren","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152388_bib0013","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152388_bib0014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152388_bib0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41568-020-00315-z","article-title":"Advances in germline predisposition to acute leukaemias and myeloid neoplasms","volume":"21","author":"Klco","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.seminoncol.2025.152388_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108386","article-title":"Genetic predisposition to lymphomas: overview of rare syndromes and inherited familial variants","volume":"788","author":"Szmyd","year":"2021","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152388_bib0017","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10875-020-00790-x","article-title":"An update on XMEN Disease","volume":"40","author":"Ravell","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.seminoncol.2025.152388_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108722","article-title":"Cutaneous T-cell lymphoma as a unique presenting malignancy in X-linked magnesium defect with EBV infection and neoplasia (XMEN) disease","volume":"226","author":"Freeman","year":"2021","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.seminoncol.2025.152388_bib0019","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2023.06.004","article-title":"Gilbert's syndrome revisited","volume":"79","author":"V\u00edtek","year":"2023","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152388_bib0020","first-page":"1024","article-title":"[Gilbert's syndrome: hyperbilirubinemia enemy or friend]","volume":"29","author":"Xiang","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152388_bib0021","first-page":"567","article-title":"[Clinical characteristics and gene mutations of Gilbert Syndrome complicated with myeloproliferative neoplasm]","volume":"25","author":"Li","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.seminoncol.2025.152388_bib0022","article-title":"Can Gilbert's syndrome mitigate chronic lymphocytic leukemia?","volume":"17","author":"Yavorkovsky","year":"2022","journal-title":"Leuk Res Rep"},{"issue":"15","key":"10.1016\/j.seminoncol.2025.152388_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153664","article-title":"Li-Fraumeni syndrome: mutation of TP53 is a biomarker of hereditary predisposition to tumor: new insights and advances in the treatment","volume":"14","author":"Rocca","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152388_bib0024","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.5858\/2009-0015-OA.1","article-title":"Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome","volume":"134","author":"Talwalkar","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152388_bib0025","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s12094-019-02236-2","article-title":"Li-Fraumeni syndrome heterogeneity","volume":"22","author":"Gargallo","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152388_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000364","article-title":"CAR T-cell therapy for a relapsed\/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome","volume":"8","author":"Chen","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"15","key":"10.1016\/j.seminoncol.2025.152388_bib0027","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","article-title":"TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes","volume":"26","author":"Petitjean","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152388_bib0028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4161\/cc.2.1.249","article-title":"Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridol","volume":"2","author":"Pepper","year":"2003","journal-title":"Cell Cycle"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T01:46:14Z","timestamp":1753321574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0093775425000806"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152388","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline mutations in B-cell non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) and patient outcomes","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152388"}}